![](/img/cover-not-exists.png)
CN-21 * RISK MODELING FOR TEMOZOLOMIDE (TMZ)-MYELOTOXICITY IN PATIENTS WITH GLIOBLASTOMA TREATED ON RTOG 0825
Zhou, R., Scheurer, M., Vera-Bolanos, E., Gilbert, M., Bondy, M., Sulman, E., Hilsenbeck, S., Wendland, M., Brachman, D., Roof, K., Komaki, R., Deutsch, M., Andrews, D., Anderson, B., Lee, R. J., PughVolume:
16
Language:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/nou243.21
Date:
November, 2014
File:
PDF, 30 KB
english, 2014